Tiziana Life Sciences (NASDAQ:TLSA) Shares Up 1.3% – Should You Buy?

Tiziana Life Sciences Ltd (NASDAQ:TLSA) shot up 1.3% on Thursday . The stock traded as high as $0.95 and last traded at $0.91. 228,892 shares were traded during mid-day trading, an increase of 10% from the average session volume of 207,968 shares. The stock had previously closed at $0.90.

Tiziana Life Sciences Price Performance

The stock has a 50-day moving average of $0.95 and a 200 day moving average of $0.92.

Hedge Funds Weigh In On Tiziana Life Sciences

A hedge fund recently raised its stake in Tiziana Life Sciences stock. Zhang Financial LLC grew its stake in shares of Tiziana Life Sciences Ltd (NASDAQ:TLSA) by 24.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 69,387 shares of the company’s stock after buying an additional 13,500 shares during the quarter. Zhang Financial LLC owned approximately 0.07% of Tiziana Life Sciences worth $67,000 as of its most recent SEC filing.

About Tiziana Life Sciences

Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases.